Curiox Biosystems Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	5,152	4,588	6,788	7,237	5,523
Other Revenue	-	-	-	-0	-
Revenue	5,152	4,588	6,788	7,237	5,523
Revenue Growth (YoY)	12.29%	-32.41%	-6.21%	31.04%	25.97%
Cost of Revenue	3,016	2,029	2,963	2,504	2,029
Gross Profit	2,135	2,559	3,825	4,733	3,494
Selling, General & Admin	10,075	11,654	10,626	13,217	10,129
Research & Development	2,615	2,504	2,109	1,470	459.64
Amortization of Goodwill & Intangibles	1,210	1,134	1,081	1,041	946.51
Other Operating Expenses	-	-	-	41.27	23.69
Operating Expenses	14,450	15,937	14,382	16,154	11,831
Operating Income	-12,314	-13,378	-10,557	-11,421	-8,337
Interest Expense	-1,189	-702.03	-25.7	-2,777	-1,704
Interest & Investment Income	537.49	549.58	236.06	162.94	28.59
Currency Exchange Gain (Loss)	-81.15	1,433	117.78	42.83	338.5
Other Non Operating Income (Expenses)	-13,793	4,225	4.93	2,714	-4,935
EBT Excluding Unusual Items	-26,840	-7,873	-10,224	-11,278	-14,609
Gain (Loss) on Sale of Assets	-68.44	-123.27	13.02	-12.11	-
Asset Writedown	-423.21	-	-	-	-84.1
Pretax Income	-27,332	-7,996	-10,211	-11,290	-14,693
Income Tax Expense	-154.37	93.67	-169.26	207.32	-167.52
Earnings From Continuing Operations	-27,178	-8,089	-10,042	-11,498	-14,525
Minority Interest in Earnings	0.84	0.47	1.28	3	1.31
Net Income	-27,177	-8,089	-10,040	-11,495	-14,524
Net Income to Common	-27,177	-8,089	-10,040	-11,495	-14,524
Shares Outstanding (Basic)	17	16	14	7	13
Shares Outstanding (Diluted)	17	16	14	7	13
Shares Change (YoY)	2.73%	12.50%	101.43%	-45.55%	-
EPS (Basic)	-1645.00	-503.00	-702.41	-1619.76	-1114.48
EPS (Diluted)	-1645.00	-503.00	-702.41	-1619.76	-1114.50
Free Cash Flow	-11,245	-9,956	-8,376	-10,711	-5,387
Free Cash Flow Per Share	-680.67	-619.10	-585.95	-1509.32	-413.36
Gross Margin	41.45%	55.77%	56.35%	65.40%	63.27%
Operating Margin	-239.04%	-291.61%	-155.53%	-157.81%	-150.95%
Profit Margin	-527.55%	-176.32%	-147.92%	-158.83%	-262.98%
Free Cash Flow Margin	-218.29%	-217.02%	-123.39%	-148.00%	-97.54%
EBITDA	-9,441	-10,800	-8,605	-9,823	-7,101
EBITDA Margin	-183.27%	-235.41%	-126.77%	-135.73%	-128.58%
D&A For EBITDA	2,873	2,578	1,952	1,598	1,236
EBIT	-12,314	-13,378	-10,557	-11,421	-8,337
EBIT Margin	-239.04%	-291.61%	-155.53%	-157.81%	-150.95%
Advertising Expenses	456.98	544.76	775.87	939.61	397.57

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.